PM Humpert, Z Djuric, S Kopf, G Rudofsky, M … - Cardiovascular Diabetology, 2007 - cardiab.com In bivariate analysis, sRAGE correlated with age (R = 0.22, p = 0.02) and the 24
hour albumin excretion rate (R = 0.18, p = 0.05), while esRAGE correlated
positively with age only (R = 0.23, p = 0.02). In contrast to previous ... Cited by 47 - Related articles - Cached - All 10 versions
K Nakamura, S Yamagishi, H Adachi, Y Kurita … - Molecular Medicine, 2007 - pubmedcentral.nih.gov Advanced glycation end products (AGEs) and their receptor (RAGE) play an
important role in accelerated atherosclerosis in diabetes. We have recently
found that the soluble form of RAGE (sRAGE) levels are significantly higher ... Cited by 41 - Related articles - BL Direct - All 5 versions
- ►fasebj.org BI Hudson, AM Carter, E Harja, AZ Kalea, M … - The FASEB Journal, 2008 - FASEB The receptor for advanced glycation end-products (RAGE) is a
single-transmembrane, multiligand receptor of the immunoglobulin superfamily.
RAGE up-regulation is implicated in numerous pathological states including ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►endojournals.org G Basta, AM Sironi, G Lazzerini, S Del Turco, E … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Results: Plasma sRAGE was lower in diabetic patients than controls [141
(53–345) vs. 735 (519–1001) pg/ml, median (interquartile range), P <
0.0001], whereas CML levels were higher in diabetic patients than controls ... Cited by 42 - Related articles - BL Direct - All 3 versions
A Bierhaus, DM Stern, PP Nawroth - Current Opinion in Investigational Drugs, 2006 - biomedcentral.com Keywords: Advanced glycation end product, chronic inflammation, high-molecular
group box 1-protein, nuclear factor-κB, S100/calgranulin, septicemia ...
Introduction The receptor of advanced glycation end products (RAGE) is a ... Cited by 41 - Related articles - View as HTML - BL Direct - All 3 versions
- ►endojournals.org AM Vincent, L Perrone, KA Sullivan, C Backus … - Endocrinology, 2007 - Endocrine Soc The receptor for advanced glycation end products (RAGE) may promote diabetic
vascular and renal disease through the activation of intracellular signaling
pathways that promote oxidative stress. Oxidative stress is a mediator of ... Cited by 39 - Related articles - BL Direct - All 6 versions
KCB Tan, SWM Shiu, WS Chow, L Leng, R … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis Activation of the receptor for advanced glycation end
products (RAGE, also known as AGE- specific receptor [AGER]) has been implicated
in the development of diabetic vascular complications. Blockade of RAGE ... Cited by 39 - Related articles - All 5 versions
M Kalousová, M Hodková, M Kazderová, J … - American Journal of Kidney Diseases, 2006 - Elsevier Background: Advanced glycation end products (AGEs) accumulate in patients with
decreased renal function and exert various toxic effects through the receptor
for AGEs (RAGE). Soluble RAGE (sRAGE) is a naturally occurring inhibitor of ... Cited by 32 - Related articles - All 3 versions
G Basta - Atherosclerosis, 2008 - Elsevier The interaction of RAGE–ligands effectively modulates several steps of
atherogenesis, triggering an inflammatory-proliferative process and furthermore,
critically contributing to propagation of vascular perturbation, mainly in ... Cited by 40 - Related articles - All 20 versions
H Koyama, T Shoji, S Fukumoto, K Shinohara, … - Arteriosclerosis Thrombosis and Vascular Biology, 2007 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Low Circulating Endogenous Secretory ... Cited by 32 - Related articles - All 7 versions
